Related Experiment Video

Updated: Aug 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Maternal smoking effects on infant growth

María del Rocio Berlanga1, Gabriela Salazar, Carola Garcia

  • 1Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile.

Food and Nutrition Bulletin
|October 5, 2002
PubMed

The influence of maternal smoking the nutrient content of breastmilk and impact on infant longitudinal growth rate is unknown. From birth, 23 smoking (S), (7.1 +/- 4.4 cigarettes/day) and 23 non-smoking (NS) mother-infant pairs were followed. The breastmilk volume by deuterium dilution, zinc (Zn), copper (Cu), and iron (Fe) in breastmilk and hair by atomic absorption (AAS) and cotinine levels by radio-immuno-analysis (RIA) were evaluated. Birthweight was similar in contrast to height, and infants grew normally. Height and height-for-age (ZHA) were significantly lower in S infants and weight-for-height (ZWH) was higher in S infants in the third month, caused by slower height growth. Cotinine was 19 times greater in the S mothers and six times higher in their infants, as compared to NS group. Breastmilk volume was 743 +/- 119 g/day (S) and 742 +/- 111 g/day (NS), with no difference in zinc, copper, iron contents, except for cadmium (Cd). In infant's hair, all minerals were higher in the S group. Smoking affected infant's height during breastfeeding, attributed to an eventual impaired bioavailability of essential nutrients.

More Related Videos

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...